C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
TSNDF US MSO

TerrAscend Corp.

OTCMKTS · TSNDF

Multi-state cannabis operator with presence in the US and Canada. Known for high-quality cultivation.

$0.48
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
54/100 composite
Fundamentals72
Regulatory58
Market40
Editorial30
Composite · trailing 12 months

TerrAscend carries a Neutral rating at a 54.2 composite score, with conviction at two out of five. Fundamentals provides the principal contribution at 72 points, led by gross-margin, operating-margin, and cash-runway subscores of roughly 87, 90, and 90, respectively. Regulatory contributes 58 points, supported by an 80-point jurisdiction posture and no enforcement hits, although weak cadence limits the pillar. Market contributes 40 points because no institutional quote is available, while editorial contributes 30 points amid no newsroom or brief activity. The resulting profile places TerrAscend in the Neutral band: operating performance is comparatively strong, but limited market confirmation, sparse coverage, and a stretched financial condition constrain rating upside.

Licensed fundamentals data show year-over-year revenue growth of approximately 2%, a modest pace relative to the strength of profitability metrics. Gross margin stands near 52%, while operating margin approaches 18%, validating the high margin subscores and establishing fundamentals as the clear rating anchor. EBITDA totals approximately $59.6 million, but net income remains a loss of about $81.7 million. That divergence supports the positive cash-runway subscore without changing the stretched financial condition or offsetting bottom-line pressure. Market capitalization is approximately $212.4 million. Primary regulatory filings show the latest filing dated June 29, 2026, with no events during the latest 90-day period and three across 180 days. The 25-point cadence subscore captures that limited near-term filing activity, despite an 80-point enforcement subscore. Institutional pricing feeds provide no current quote, and CIN newsroom coverage records no qualifying news or brief hits.

The clearest catalyst lies within the 72-point fundamentals pillar. Sustained gross and operating margins can create a stronger earnings profile if revenue growth advances beyond its current low-single-digit rate and EBITDA converts more effectively into net income. Such conversion would reinforce the strongest existing drivers while directly addressing the stretched condition that caps conviction. Regulatory cadence, market-price availability, and newsroom activity can improve visibility, but none carries the same rating leverage as fundamental earnings conversion. The single most important signal to watch is whether positive EBITDA begins translating into a materially smaller net loss.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
Headquarters
3610 MAVIS ROAD, MISSISSAUGA, A6, L5B 4A7
Phone
855 837-7295
CEO
Ziad Ghanem
CFO
Eric Jackson
SEC CIK
1778129
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$212.4M
Enterprise value
$390.9M
Price to book
2.00
Price to sales
0.81
EV / EBITDA
6.45
Revenue (TTM)
$261.8M
Gross profit (TTM)
$136.2M
EBITDA
$59.6M
Operating margin
17.6%
Profit margin
-31.2%
Rev growth YoY
1.9%
Return on equity
-18.5%
Return on assets
4.8%
EPS (TTM)
$-0.10
EPS est. current year
$-0.06
Wall St. target price
$1.50
Shares outstanding
309.2M
Insider ownership
5.5%
Institutional ownership
14.3%
Beta
2.02
Full-time employees
828
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Annual report
Latest 10-K
Proxy statement
Latest DEF 14A
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for TerrAscend Corp. (TSNDF)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for TerrAscend Corp. (TSNDF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss. (1 bullish signal, 3 bearish signals.)

Bullish and bearish analyst opinions for TerrAscend Corp. (TSNDF)

Bullish view. TerrAscend's New Jersey and Maryland footprint gives it exposure to two of the highest-margin adult-use markets in the US, and bulls point to the pending Canada-to-US uplisting optionality if federal reform advances.

Bearish view. Bears cite leverage, ongoing cash burn, and reliance on a small handful of state markets for the bulk of EBITDA.

Live ratings, price targets, and consensus figures for TerrAscend Corp. appear above this summary. Explore analyst coverage across the 326-equity cannabis universe.

Multi-state cannabis operator with presence in the US and Canada. Known for high-quality cultivation.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for TSNDF are maintained by Cannabis Investor News and refreshed throughout the trading day.